Global Hereditary Angioedema Therapeutic Market Size, Status and Forecast 2024-2031

Report ID: 950198 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Intravenous
        1.2.3 Subcutaneous
        1.2.4 Oral
    1.3 Market by Application
        1.3.1 Global Hereditary Angioedema Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Hereditary Angioedema Therapeutic Market Perspective (2016-2027)
    2.2 Hereditary Angioedema Therapeutic Growth Trends by Regions
        2.2.1 Hereditary Angioedema Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Hereditary Angioedema Therapeutic Historic Market Share by Regions (2016-2021)
        2.2.3 Hereditary Angioedema Therapeutic Forecasted Market Size by Regions (2022-2027)
    2.3 Hereditary Angioedema Therapeutic Industry Dynamic
        2.3.1 Hereditary Angioedema Therapeutic Market Trends
        2.3.2 Hereditary Angioedema Therapeutic Market Drivers
        2.3.3 Hereditary Angioedema Therapeutic Market Challenges
        2.3.4 Hereditary Angioedema Therapeutic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue
        3.1.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue (2016-2021)
        3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2016-2021)
    3.2 Global Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Hereditary Angioedema Therapeutic Revenue
    3.4 Global Hereditary Angioedema Therapeutic Market Concentration Ratio
        3.4.1 Global Hereditary Angioedema Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hereditary Angioedema Therapeutic Revenue in 2020
    3.5 Hereditary Angioedema Therapeutic Key Players Head office and Area Served
    3.6 Key Players Hereditary Angioedema Therapeutic Product Solution and Service
    3.7 Date of Enter into Hereditary Angioedema Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Hereditary Angioedema Therapeutic Breakdown Data by Type
    4.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Type (2016-2021)
    4.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2022-2027)

5 Hereditary Angioedema Therapeutic Breakdown Data by Application
    5.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Application (2016-2021)
    5.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Hereditary Angioedema Therapeutic Market Size (2016-2027)
    6.2 North America Hereditary Angioedema Therapeutic Market Size by Type
        6.2.1 North America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
        6.2.2 North America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
        6.2.3 North America Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
    6.3 North America Hereditary Angioedema Therapeutic Market Size by Application
        6.3.1 North America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
        6.3.2 North America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
        6.3.3 North America Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
    6.4 North America Hereditary Angioedema Therapeutic Market Size by Country
        6.4.1 North America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
        6.4.2 North America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Hereditary Angioedema Therapeutic Market Size (2016-2027)
    7.2 Europe Hereditary Angioedema Therapeutic Market Size by Type
        7.2.1 Europe Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
        7.2.2 Europe Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
        7.2.3 Europe Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
    7.3 Europe Hereditary Angioedema Therapeutic Market Size by Application
        7.3.1 Europe Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
        7.3.2 Europe Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
        7.3.3 Europe Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
    7.4 Europe Hereditary Angioedema Therapeutic Market Size by Country
        7.4.1 Europe Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
        7.4.2 Europe Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size (2016-2027)
    8.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type
        8.2.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application
        8.3.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region
        8.4.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Hereditary Angioedema Therapeutic Market Size (2016-2027)
    9.2 Latin America Hereditary Angioedema Therapeutic Market Size by Type
        9.2.1 Latin America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
        9.2.2 Latin America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
        9.2.3 Latin America Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
    9.3 Latin America Hereditary Angioedema Therapeutic Market Size by Application
        9.3.1 Latin America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
        9.3.2 Latin America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
        9.3.3 Latin America Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
    9.4 Latin America Hereditary Angioedema Therapeutic Market Size by Country
        9.4.1 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
        9.4.2 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size (2016-2027)
    10.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type
        10.2.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application
        10.3.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country
        10.4.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 BioCryst Pharma
        11.1.1 BioCryst Pharma Company Details
        11.1.2 BioCryst Pharma Business Overview
        11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Introduction
        11.1.4 BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.1.5 BioCryst Pharma Recent Development
    11.2 Ionis Pharma
        11.2.1 Ionis Pharma Company Details
        11.2.2 Ionis Pharma Business Overview
        11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Introduction
        11.2.4 Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.2.5 Ionis Pharma Recent Development
    11.3 Pharming Group
        11.3.1 Pharming Group Company Details
        11.3.2 Pharming Group Business Overview
        11.3.3 Pharming Group Hereditary Angioedema Therapeutic Introduction
        11.3.4 Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.3.5 Pharming Group Recent Development
    11.4 CSL Limited
        11.4.1 CSL Limited Company Details
        11.4.2 CSL Limited Business Overview
        11.4.3 CSL Limited Hereditary Angioedema Therapeutic Introduction
        11.4.4 CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.4.5 CSL Limited Recent Development
    11.5 Shire
        11.5.1 Shire Company Details
        11.5.2 Shire Business Overview
        11.5.3 Shire Hereditary Angioedema Therapeutic Introduction
        11.5.4 Shire Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.5.5 Shire Recent Development
    11.6 Attune Pharma
        11.6.1 Attune Pharma Company Details
        11.6.2 Attune Pharma Business Overview
        11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Introduction
        11.6.4 Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.6.5 Attune Pharma Recent Development
    11.7 Adverum Biotechnologies
        11.7.1 Adverum Biotechnologies Company Details
        11.7.2 Adverum Biotechnologies Business Overview
        11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Introduction
        11.7.4 Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.7.5 Adverum Biotechnologies Recent Development
    11.8 KalVista Pharma
        11.8.1 KalVista Pharma Company Details
        11.8.2 KalVista Pharma Business Overview
        11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Introduction
        11.8.4 KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021)
        11.8.5 KalVista Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Intravenous
    Table 3. Key Players of Subcutaneous
    Table 4. Key Players of Oral
    Table 5. Global Hereditary Angioedema Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Hereditary Angioedema Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Hereditary Angioedema Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Hereditary Angioedema Therapeutic Market Share by Regions (2016-2021)
    Table 9. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Hereditary Angioedema Therapeutic Market Share by Regions (2022-2027)
    Table 11. Hereditary Angioedema Therapeutic Market Trends
    Table 12. Hereditary Angioedema Therapeutic Market Drivers
    Table 13. Hereditary Angioedema Therapeutic Market Challenges
    Table 14. Hereditary Angioedema Therapeutic Market Restraints
    Table 15. Global Hereditary Angioedema Therapeutic Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Hereditary Angioedema Therapeutic Market Share by Players (2016-2021)
    Table 17. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Therapeutic as of 2020)
    Table 18. Ranking of Global Top Hereditary Angioedema Therapeutic Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Hereditary Angioedema Therapeutic Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Hereditary Angioedema Therapeutic Product Solution and Service
    Table 22. Date of Enter into Hereditary Angioedema Therapeutic Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2016-2021)
    Table 26. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Hereditary Angioedema Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2016-2021)
    Table 30. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. BioCryst Pharma Company Details
    Table 63. BioCryst Pharma Business Overview
    Table 64. BioCryst Pharma Hereditary Angioedema Therapeutic Product
    Table 65. BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 66. BioCryst Pharma Recent Development
    Table 67. Ionis Pharma Company Details
    Table 68. Ionis Pharma Business Overview
    Table 69. Ionis Pharma Hereditary Angioedema Therapeutic Product
    Table 70. Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 71. Ionis Pharma Recent Development
    Table 72. Pharming Group Company Details
    Table 73. Pharming Group Business Overview
    Table 74. Pharming Group Hereditary Angioedema Therapeutic Product
    Table 75. Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 76. Pharming Group Recent Development
    Table 77. CSL Limited Company Details
    Table 78. CSL Limited Business Overview
    Table 79. CSL Limited Hereditary Angioedema Therapeutic Product
    Table 80. CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 81. CSL Limited Recent Development
    Table 82. Shire Company Details
    Table 83. Shire Business Overview
    Table 84. Shire Hereditary Angioedema Therapeutic Product
    Table 85. Shire Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 86. Shire Recent Development
    Table 87. Attune Pharma Company Details
    Table 88. Attune Pharma Business Overview
    Table 89. Attune Pharma Hereditary Angioedema Therapeutic Product
    Table 90. Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 91. Attune Pharma Recent Development
    Table 92. Adverum Biotechnologies Company Details
    Table 93. Adverum Biotechnologies Business Overview
    Table 94. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product
    Table 95. Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 96. Adverum Biotechnologies Recent Development
    Table 97. KalVista Pharma Company Details
    Table 98. KalVista Pharma Business Overview
    Table 99. KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2016-2021) & (US$ Million)
    Table 100. KalVista Pharma Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hereditary Angioedema Therapeutic Market Share by Type: 2020 VS 2027
    Figure 2. Intravenous Features
    Figure 3. Subcutaneous Features
    Figure 4. Oral Features
    Figure 5. Global Hereditary Angioedema Therapeutic Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Hereditary Angioedema Therapeutic Report Years Considered
    Figure 10. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Hereditary Angioedema Therapeutic Market Share by Regions: 2020 VS 2027
    Figure 13. Global Hereditary Angioedema Therapeutic Market Share by Regions (2022-2027)
    Figure 14. Global Hereditary Angioedema Therapeutic Market Share by Players in 2020
    Figure 15. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Therapeutic as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Hereditary Angioedema Therapeutic Revenue in 2020
    Figure 17. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2016-2021)
    Figure 18. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2022-2027)
    Figure 19. North America Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
    Figure 21. North America Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
    Figure 22. North America Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
    Figure 23. United States Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
    Figure 27. Europe Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
    Figure 28. Europe Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
    Figure 29. Germany Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2016-2027)
    Figure 39. China Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
    Figure 47. Latin America Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
    Figure 48. Latin America Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
    Figure 49. Mexico Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Country (2016-2027)
    Figure 55. Turkey Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Hereditary Angioedema Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. BioCryst Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 59. Ionis Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 60. Pharming Group Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 61. CSL Limited Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 62. Shire Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 63. Attune Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 64. Adverum Biotechnologies Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 65. KalVista Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2016-2021)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Frequently Asked Questions
Hereditary Angioedema Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Angioedema Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Angioedema Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical Writing

Medical writing requires knowledge of the drug development process, understanding of research met ... Read More